In some elderly patients, levothyroxine may be linked with increased mortality

March 20, 2018

CHICAGO--Treating some elderly people with levothyroxine may put them at increased risk of death, new research from Israel reports. The results will be presented on Tuesday, March 20, at ENDO 2018, the 100th annual meeting of the Endocrine Society in Chicago, Ill.

"In patients who are 65 years of age or above with subclinical hypothyroidism and thyroid-stimulating hormone (TSH) <10 miu>

"Subclinical hypothyroidism, the situation when thyroid function is not normal but is not defined as a disease, is very common," he added. "Physicians should consider the results of the study before they begin treatment with levothyroxine in individuals 65 years of age and above who have subclinical hypothyroidism and TSH values under 10 mIU/L."

Meyerovitch and colleagues determined which patients 65 years or older with TSH levels between 4.2 and 10 mIU/L died during the years 2012 through 2016 (cases) and matched them with individuals who did not die during that period (controls).

The authors matched the patients according to age, gender, Charlson comorbidity index, TSH testing date, follow-up duration, and TSH quartile, and they compared the use of levothyroxine between the groups. They excluded all patients with known thyroid disease and those who had received anti-thyroid medications or glucocorticoids in the year before they were tested for TSH.

During the follow-up period, 419 people who died were matched with 1,558 people who did not die. Treatment with levothyroxine was linked with significantly increased mortality (hazard ratio = 1.19).

Factors associated with death included age, senile dementia, congestive heart failure, cerebrovascular disease, and chronic renal failure. Femoral fractures and atrial fibrillation after beginning to take levothyroxine were not more prevalent in individuals who died during follow-up.
Endocrinologists are at the core of solving the most pressing health problems of our time, from diabetes and obesity to infertility, bone health, and hormone-related cancers. The Endocrine Society is the world's oldest and largest organization of scientists devoted to hormone research and physicians who care for people with hormone-related conditions.

The Society has more than 18,000 members, including scientists, physicians, educators, nurses and students in 122 countries. To learn more about the Society and the field of endocrinology, visit our site at Follow us on Twitter at @TheEndoSociety and @EndoMedia.

The Endocrine Society

Related Thyroid Articles from Brightsurf:

Thyroid inflammation linked to anxiety disorders
Patients with autoimmune inflammation of their thyroid may be at greater risk of developing anxiety, according to a study being presented at e-ECE 2020.

Some physicians are ordering thyroid tests for unsupported reasons
Up to one-third of physicians reported sending patients for a thyroid ultrasound for reasons not supported by clinical care guidelines, a new study led by University of Michigan Rogel Cancer Center researchers finds.

Trends in the global burden of thyroid cancer
This study examined the worldwide trends of thyroid cancer from 1990 to 2017 according to geographic location, sex, age and socioeconomic factors.

Thyroid dysfunction in pregnancy being overdiagnosed, overtreated
The current practice of testing most pregnant women for thyroid stimulating hormone (TSH) may be leading to overdiagnosis and overtreatment, according to new research in CMAJ (Canadian Medical Association Journal).

Patients with COVID-19 may develop thyroid infection
COVID-19 infection may cause subacute thyroiditis, according to a new case study published in The Journal of Clinical Endocrinology & Metabolism.

Thyroid cancer rates in US
An analysis suggests rates of thyroid cancer in the US appear to have plateaued in recent years after decades on the rise.

New test for thyroid cancer could prevent unnecessary surgery
Each year, thanks to inconclusive tests for thyroid cancer, thousands of people undergo unnecessary surgeries to remove part or all of their thyroids.

New radiomics model uses immunohistochemistry to predict thyroid nodules
American Journal of Roentgenology researchers have validated a first-of-its-kind machine learning-based model to evaluate immunohistochemical characteristics in patients with suspected thyroid nodules, achieving 'excellent performance' for individualized noninvasive prediction of the presence of cytokeratin 19, galectin 3, and thyroperoxidase based upon CT images.

Thyroid screening may not be needed in all youth with psychiatric disorders
A new study from researchers at the University of Cincinnati (UC) and Cincinnati Children's looks at the prevalence of abnormal thyroid function in youth with severe mood and anxiety disorder.

Are doctors treating more thyroid cancer patients than necessary?
New research may help change treatment practices for patients diagnosed with low risk thyroid cancer.

Read More: Thyroid News and Thyroid Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to